tiprankstipranks
Trending News
More News >
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Compare Arcturus Therapeutics (ARCT) vs. Competitors

Compare
2,153 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arcturus Therapeutics
$6.63
$195.27M
-1.44
-46.66%
7 Buy
3 Hold
0 Sell
Moderate Buy
Rigel
$26.50
$489.54M
2.10
31.19%
2 Buy
2 Hold
0 Sell
Moderate Buy
Arvinas Holding Company
$10.94
$660.08M
-9.53
17.94%
8 Buy
6 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$5.15
$907.64M
-12.74
118.18%
8 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$14.08
$1.22B
-13.39
230.26%
11 Buy
0 Hold
0 Sell
Strong Buy
Erasca
$14.60
$4.45B
-8.47
835.95%
7 Buy
1 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARCT
Arcturus Therapeutics
6.87
-6.40
-48.23%
RIGL
Rigel
26.50
5.96
29.02%
ARVN
Arvinas Holding Company
10.32
1.71
19.86%
CMPX
Compass Therapeutics
5.04
2.67
112.66%
OLMA
Olema Pharmaceuticals
13.97
9.65
223.38%
ERAS
Erasca
14.32
12.83
861.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts